NEW YORK—An investigational triple regimen of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) may result in significantly greater mean reductions in BP compared ...
The researchers found that the proportion of patients achieving target BP was increased with the triple combination pill versus usual care at 6 months (70 vs 55%; risk difference, 12.7%). HealthDay ...
BP’s earnings tripled in the second quarter as the British energy giant profited from oil and natural gas prices that soared after Russia invaded Ukraine. London-based BP said Tuesday that underlying ...
BP will accelerate its net-zero ambitions and devote more resources to low-carbon energy, the company said Tuesday in an earnings release. In 2021, BP posted $12.85 billion in profit compared with ...
Patients who mix a diuretic and renin-angiotensin system (RAS) inhibitor with a nonsteroidal anti-inflammatory drug (NSAID) could face a higher risk of developing acute kidney injury (AKI), a new ...
LONDON - BP said its earnings from April to June almost tripled from a year earlier, increasing pressure on governments to intervene as energy companies profit from high oil and natural gas prices ...
Proportion achieving target BP increased with use of triple combo pill versus usual care at six months. TUESDAY, Aug. 14, 2018 (HealthDay News) — Treatment with a pill combining low doses of 3 ...
FILE - A BP logo is seen at a petrol station in London, Tuesday, March 8, 2022. (AP Photo/Frank Augstein, File) LONDON (AP) — BP’s earnings tripled in the second quarter as the British energy giant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback